4.7 Review

Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches

期刊

NATURE REVIEWS GENETICS
卷 14, 期 6, 页码 373-378

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrg3460

关键词

-

资金

  1. UK Medical Research Council
  2. Wellcome Trust
  3. UK Muscular Dystrophy Campaign
  4. US Muscular Dystrophy Association
  5. Action Duchenne
  6. Association Francaise Contre les Myopathies
  7. International Consortium on Exon Skipping
  8. Medical Research Council [MC_UU_12021/2, G0900887, G0801763] Funding Source: researchfish
  9. Rosetrees Trust [M164-F1] Funding Source: researchfish
  10. MRC [G0900887, MC_UU_12021/2, G0801763] Funding Source: UKRI

向作者/读者索取更多资源

Duchenne muscular dystrophy (DMD) is a devastating progressive disease for which there is currently no effective treatment except palliative therapy. There are several promising genetic approaches, including viral delivery of the missing dystrophin gene, read-through of translation stop codons, exon skipping to restore the reading frame and increased expression of the compensatory utrophin gene. The lessons learned from these approaches will be applicable to many other disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据